Szilveszter E. Vizi

Neurosciences Semmelweis Egyetem, Hungary 
Neuroscience Biology
"Szilveszter E. Vizi"
Mean distance: 53433
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Delmaghani S, Defourny J, Aghaie A, et al. (2015) Hypervulnerability to Sound Exposure through Impaired Adaptive Proliferation of Peroxisomes. Cell. 163: 894-906
Lenkey N, Kirizs T, Holderith N, et al. (2015) Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals. Nature Communications. 6: 6557
Kisfali M, Lrincz T, Vizi ES. (2013) Comparison of Ca2+ transients and [Ca2+]i in the dendrites and boutons of non-fast-spiking GABAergic hippocampal interneurons using two-photon laser microscopy and high- and low-affinity dyes. The Journal of Physiology. 591: 5541-53
Csölle C, Baranyi M, Zsilla G, et al. (2013) Neurochemical Changes in the Mouse Hippocampus Underlying the Antidepressant Effect of Genetic Deletion of P2X7 Receptors. Plos One. 8: e66547
Antonioli L, Pacher P, Vizi ES, et al. (2013) CD39 and CD73 in immunity and inflammation. Trends in Molecular Medicine. 19: 355-67
Vizi ES, Buonanno A. (2013) Editorial. Brain Research Bulletin. 93: 1-3
Vizi ES, Kisfali M, Lőrincz T. (2013) Role of nonsynaptic GluN2B-containing NMDA receptors in excitotoxicity: evidence that fluoxetine selectively inhibits these receptors and may have neuroprotective effects. Brain Research Bulletin. 93: 32-8
Katona G, Szalay G, Maák P, et al. (2012) Fast two-photon in vivo imaging with three-dimensional random-access scanning in large tissue volumes. Nature Methods. 9: 201-8
Kiss JP, Szasz BK, Fodor L, et al. (2012) GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine. Neurochemistry International. 60: 170-6
Sperlágh B, Vizi ES. (2011) The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects. Current Topics in Medicinal Chemistry. 11: 1034-46
See more...